Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures

Bone

Volumn 27, Issue 6, 2000, Pages 769-776

  Takeuchi, Y ^a   Suzawa, M ^a   Fukumoto, S ^a   Fujita, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adipocyte; Bone marrow cell; ODF RANK ligand; Osteoclast; PPAR ; Vitamin K2

Indexed keywords

TROGLITAZONE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HISTOLOGY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ANIMALS; ANTINEOPLASTIC AGENTS; BONE AND BONES; BONE MARROW CELLS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMANS; GENE EXPRESSION; HEMOSTATICS; MALE; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; VITAMIN K; VITAMIN K 2;

EID: 0033678846     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00396-3     Document Type: Article

References (41)

1. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
2. Vitamin K2 modulates proliferation and function of osteoblastic cells in vitro
3. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures
4. Osteogenic stem cells and the stromal system of bone and marrow
5. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age; a comparative histomorhometric study
6. Increased bone formation in osteocalcin-deficient mice
7. Vitamin K intake and hip fractures in women; a prospective study
8. Ectopic expression of the CCAAT/enhancer-binding protein a promotes the adipogenic program in a variety of mouse fibroblastic cells
9. Understanding adipocyte differentiation
10. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain
11. Effects of menatetrenone on prednisolone-induced bone loss in rats
12. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro
13. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
14. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ
15. Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group
16. Comparative investigation of vitamins and their analogues on terminal differentiation, from preadipocytes to adipocytes, of 3T3-L1 cells
17. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
18. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion
19. Reduced expression of interleukin-11 in bone marrow stromal cells of senescence-accelerated mice (SAMP6); Relationship to osteopenia with enhanced adipogenesis
20. Bone health of adult hemodialysis patients is related to vitamin K status
21. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro
22. 3-induced mineralization in human periosteal osteoblasts
23. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
24. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture
25. Effects of sulfonylureas on the actions of insulin and insulin-mimickers; potentiation of stimulated hexose transport in adipocytes
26. New development in the pathogenesis and treatment of steroid-induced osteoporosis
27. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
28. 3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells
29. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue
30. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
31. Thiazolidinediones inhibits osteoclast-like cell formation and bone resorption in vitro
32. Differential effects of insulin, antibodies against rat adipocyte plasma membranes, and other agents that mimic insulin action in rat adipocytes
33. Marrow stromal cells as stem cells for nonhematopoietic tissues
34. Novel role of vitamin K2; a potent inducer of differentiation of various human leukemia cell lines
35. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers; intermolecular synergy requires only the PPARγ hormone-dependent activation function
36. PPAR-γ; adipogenic regulator and thiazolidinedione receptor
37. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
38. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
39. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
40. Role of vitamin K in bone metabolism